Hollywood stars are dropping dress sizes, TikTokers are buzzing, Elon Musk says it keeps him looking “fit, ripped and healthy”: semaglutide seems to be the most-hyped drug of the moment.
The demand for semaglutide, marketed under the brand names Ozempic and Wegovy, is so high that maker Novo Nordisk has been struggling to produce enough. It belongs to a class of drugs known as GLP-1 receptor agonists that have been hailed
